Search
-
News
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
… Monday, November 4, 2013 Summary Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research. Watch the video, Cancer Research Advances and Trends, on YouTube. Few high school students get the opportunity to learn about cutting-edge science
-
News
philanthropist and art collector Iris Cantor has made a major commitment to Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers.
… Wednesday, April 18, 2007 Philanthropist and art collector Iris Cantor has made a major commitment to New York’s Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers. Mrs. Cantor is establishing the position with support totaling
-
News
Take a look back at some of the biggest cancer science stories from this past year.
… Monday, December 21, 2020 Summary Many advances in cancer care come from applying the insights of basic science. This past year, Memorial Sloan Kettering scientists made fundamental discoveries that have direct relevance to cancer treatment. Below are ten of our favorites. 1. Good news for people with
-
News
A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease.
… Thursday, October 15, 2020 A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease. Members of the MSK community joined the session to have their most pressing
-
News
The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
… Monday, February 15, 2021 Summary Experts in pediatric cancer genetics have found that inherited cancer genes are more common than expected in children with cancer. Because cancers in children are rare, many details about their biology remain unknown. In the field of cancer genetics, there’s a limited
-
News
Experience the words and artwork of three patients who found hope and healing through MSK art programs.
… Thursday, January 24, 2019 Summary Three patients share how MSK’s art-making programs helped them express their emotions and heal during their cancer treatment. Making art can be a powerful form of therapy. It can be especially beneficial for people with cancer, helping them to cope better with physical
-
News
… Monday, October 6, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Maria Jasin Awarded the 2025 Peral Meister Greengard Prize Maria Jasin Maria Jasin, PhD , developmental biologist and William E. Snee Chair, has been selected as the 2025 recipient
-
News
Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
… Wednesday, August 17, 2022 More than half of all cancers have mutations in a gene called p53 . The protein made from this gene is what’s called a tumor suppressor: When working properly, it guards against cancer development — in part, by detecting damaged DNA and alerting cells to repair it. Cells without
-
News
Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors are able to prescribe treatments that are most likely to be effective for patients, while avoiding drugs that will provide no benefit and may cause serious side effects.
… Friday, October 1, 2010 Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors may be able to prescribe
-
News
Learn about the work of Nai-Kong Cheung and other MSK scientists who have learned more about how to deliver stronger treatment with less toxicity.
… Tuesday, December 29, 2020 Summary MSK scientists have learned more about how to deliver stronger treatment with less toxicity. Giving drugs without toxic side effects is a primary goal of cancer treatment. This can be especially challenging for radioimmunotherapy, a form of liquid radiation. Radioimmunotherapy